Thursday 26 September 2019

New studies question whether novel anti-cancer drugs are worth their extra cost

Many new anti-cancer medicines add little value for patients compared to standard treatment and are rarely worth the extra cost, according to results of two studies investigating links between clinical benefit and pricing in Europe and the USA, reported at the ESMO Congress 2019.

Researchers release reports on economic impacts of MGM Springfield

In two highly anticipated reports about the economic impacts of MGM Springfield, University of Massachusetts Amherst researchers found that the resort-casino's construction was felt in every corner of the Commonwealth, and its development has been part of the strengthening housing and real estate markets of Greater Springfield.

Clinical trial to test potential new therapy for giant cell arteritis

An international, multicenter phase II clinical trial is evaluating the efficacy and safety of mavrilimumab co-administered with a 26-week corticosteroid taper in patients with giant cell arteritis (GCA). The study is sponsored by Kiniksa Pharmaceuticals, Ltd. Hospital for Special Surgery (HSS), in New York City, is one of the centers participating in the research.

Air pollution linked to increased risk of infant death and reduced lung function in children

Air pollution is linked to an increased risk of death in babies according to a study of nearly eight million live births, to be presented at the European Respiratory Society International Congress on Sunday.

First large-scale study of universal screening for autism raises questions about accuracy

In the first large, real-world study of universal screening for autism spectrum disorder (ASD) in toddlers, researchers at Children's Hospital of Philadelphia (CHOP) have found that the most widely used and researched screening tool is less accurate than shown in previous studies conducted in research laboratory settings. The new study also revealed significant disparities in detecting early autism symptoms in minority, urban and low-income children. The findings were published online today in the journal Pediatrics.

New calculator will help clinicians diagnose diabetes more accurately

A new calculator developed by the University of Exeter will help clinicians classify whether a patient has type 1 or type 2 diabetes, ensuring they get the best treatment and reducing complications.

Using the immune system as a defence against cancer

Research published today in the British Journal of Cancer has found that a naturally occurring molecule and a component of the immune system that can successfully target and kill cancer cells, can also encourage immunity against cancer resurgence.

Teenagers less likely to respond to mothers with controlling tone of voice

Teenagers are less likely to cooperate and put effort into their mother's requests when they are said in a controlling tone of voice, researchers have found.